Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 22 studies | 29% ± 10% | |
| endothelial cell | 15 studies | 25% ± 11% | |
| ciliated cell | 13 studies | 25% ± 9% | |
| astrocyte | 13 studies | 32% ± 15% | |
| pericyte | 13 studies | 21% ± 6% | |
| smooth muscle cell | 12 studies | 21% ± 4% | |
| oligodendrocyte | 12 studies | 40% ± 15% | |
| connective tissue cell | 9 studies | 25% ± 5% | |
| macrophage | 9 studies | 22% ± 5% | |
| oligodendrocyte precursor cell | 9 studies | 40% ± 17% | |
| glutamatergic neuron | 7 studies | 43% ± 28% | |
| GABAergic neuron | 7 studies | 42% ± 24% | |
| endothelial cell of lymphatic vessel | 6 studies | 20% ± 3% | |
| mast cell | 5 studies | 27% ± 8% | |
| epithelial cell | 5 studies | 35% ± 7% | |
| adipocyte | 5 studies | 23% ± 8% | |
| Mueller cell | 5 studies | 35% ± 11% | |
| basal cell | 5 studies | 22% ± 5% | |
| classical monocyte | 4 studies | 19% ± 2% | |
| myofibroblast cell | 4 studies | 24% ± 7% | |
| myeloid cell | 4 studies | 23% ± 4% | |
| retina horizontal cell | 4 studies | 28% ± 5% | |
| retinal cone cell | 4 studies | 38% ± 3% | |
| type I pneumocyte | 3 studies | 18% ± 1% | |
| hematopoietic precursor cell | 3 studies | 26% ± 7% | |
| retinal ganglion cell | 3 studies | 41% ± 8% | |
| amacrine cell | 3 studies | 20% ± 5% | |
| retinal pigment epithelial cell | 3 studies | 39% ± 17% | |
| retinal rod cell | 3 studies | 20% ± 2% | |
| ependymal cell | 3 studies | 39% ± 18% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 12% | |
| endothelial cell of vascular tree | 3 studies | 22% ± 3% | |
| interneuron | 3 studies | 58% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 4448.36 | 2640 / 2642 | 100% | 50.17 | 703 / 705 |
| thymus | 100% | 4969.44 | 653 / 653 | 99% | 36.16 | 600 / 605 |
| kidney | 100% | 4052.94 | 89 / 89 | 98% | 43.11 | 883 / 901 |
| adrenal gland | 100% | 6886.56 | 258 / 258 | 97% | 28.54 | 224 / 230 |
| skin | 100% | 4540.61 | 1808 / 1809 | 97% | 41.72 | 456 / 472 |
| breast | 100% | 5935.05 | 459 / 459 | 97% | 26.58 | 1079 / 1118 |
| ovary | 100% | 8876.53 | 180 / 180 | 95% | 18.47 | 407 / 430 |
| lung | 100% | 4837.42 | 577 / 578 | 92% | 21.50 | 1061 / 1155 |
| prostate | 100% | 4991.80 | 244 / 245 | 91% | 21.56 | 459 / 502 |
| uterus | 100% | 7414.51 | 170 / 170 | 90% | 21.83 | 414 / 459 |
| bladder | 100% | 6087.38 | 21 / 21 | 79% | 17.77 | 398 / 504 |
| esophagus | 99% | 4603.75 | 1433 / 1445 | 67% | 15.11 | 123 / 183 |
| pancreas | 66% | 869.34 | 218 / 328 | 94% | 20.22 | 167 / 178 |
| stomach | 98% | 3101.99 | 353 / 359 | 46% | 6.66 | 131 / 286 |
| intestine | 94% | 4574.54 | 904 / 966 | 29% | 4.44 | 152 / 527 |
| adipose | 100% | 6346.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6910.66 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3550.76 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.25 | 1 / 1 |
| muscle | 100% | 3265.85 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 2647.19 | 826 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 28.19 | 74 / 80 |
| liver | 58% | 760.77 | 131 / 226 | 22% | 3.03 | 90 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 13.41 | 36 / 45 |
| peripheral blood | 60% | 923.98 | 555 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 5.60 | 15 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009838 | Biological process | abscission |
| GO_0048669 | Biological process | collateral sprouting in absence of injury |
| GO_0051301 | Biological process | cell division |
| GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
| GO_0050905 | Biological process | neuromuscular process |
| GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
| GO_0030509 | Biological process | BMP signaling pathway |
| GO_0034389 | Biological process | lipid droplet organization |
| GO_0060612 | Biological process | adipose tissue development |
| GO_0048698 | Biological process | negative regulation of collateral sprouting in absence of injury |
| GO_0030496 | Cellular component | midbody |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005811 | Cellular component | lipid droplet |
| GO_0005829 | Cellular component | cytosol |
| GO_0045202 | Cellular component | synapse |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0031625 | Molecular function | ubiquitin protein ligase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SPART |
| Protein name | Spastic paraplegia 20 isoform 2 Spastic paraplegia 20, spartin (Troyer syndrome), isoform CRA_b (cDNA FLJ11087 fis, clone PLACE1005277, highly similar to Spartin) Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1) Spastic paraplegia 20 isoform 1 (Spastic paraplegia 20, spartin (Troyer syndrome), isoform CRA_a) |
| Synonyms | KIAA0610 SPG20 TAHCCP1 hCG_32832 |
| Description | FUNCTION: May be implicated in endosomal trafficking, or microtubule dynamics, or both. Participates in cytokinesis . . |
| Accessions | ENST00000494062.2 ENST00000438666.7 A0A0S2Z510 ENST00000355182.8 A0A024RDV9 B3KMI3 Q8N0X7 ENST00000451493.5 ENST00000650221.1 |